Because immediate reconstruction was an exclusion criterion, there was only one patient (in the COX-2 inhibition group) that underwent reconstruction by insertion of a tissue expander and subpectoral prosthesis implantation (495 cc, Mentor©, Minneapolis, MN, USA) in the year following the initial breast cancer surgery. This evidence concerns the gene PTGS2 and breast carcinoma.